Full-length thymosin beta-4 has a short plasma half-life, which is one reason twice-weekly dosing is commonly used
TB-500 promotes broader repair and flexibility Dosing synergy: BPC-157: 250500mcg 12x daily (local injection) TB-500: 25mg weekly (divided into 23 doses, SubQ or IM) TB-500 (thymosin beta-4) enhances angiogenesis and cellular differentiation, making it synergistic with BPC-157 in musculoskeletal recovery. Goldstein, A
Research remains pre-clinical and investigational , focused on understanding molecular signaling behavior rather than clinical application
[DOI] [PubMed] [Google Scholar] 106.Balenovic D., Barisic I., Prkacin I., Horvat I., Udovicic M., Uzun S., Strinic D., Pevec D., Drmic D., Radic B., et al